KATRINA LYNN LAMONT
DALLAS, TX
Browse related groups: TX Retrophin, Inc. All categories
General Payments — all program years on this page
$214.19
- Category: General Payments
- Program years: PY2023
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $214.19 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.19 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $214.19 | 7 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2023 | $214.19 | 7 |
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1059580201 | Travere Therapeutics, Inc. | $21.89 | 11/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059580205 | Travere Therapeutics, Inc. | $25.24 | 09/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059580213 | Travere Therapeutics, Inc. | $25.74 | 10/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059580219 | Travere Therapeutics, Inc. | $33.00 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059580225 | Travere Therapeutics, Inc. | $33.38 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059580231 | Travere Therapeutics, Inc. | $37.18 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059580237 | Travere Therapeutics, Inc. | $37.76 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.